Translator Disclaimer
1 October 2000 UNEXPECTED ACTIVITY OF β-CYCLODEXTRIN AGAINST EXPERIMENTAL INFECTION BY CRYPTOSPORIDIUM PARVUM
Author Affiliations +
Abstract

An unexpected activity of β-cyclodextrin, an excipient used in pharmaceutical technology, was observed against Cryptosporidium parvum. The viability and infectivity of purified oocysts, exposed for 24 hr to β-cyclodextrin (2.5% suspension), were evaluated by inclusion/exclusion of 2 fluorogenic vital dyes and a suckling murine model, respectively. Results of the viability assay showed a high proportion of nonviable oocysts (81.5%). The intensity of experimental infection, determined 7 days postinoculation by examination of intestinal homogenates, was significantly lower (P < 0.05) than in the control litters. The preventive and curative efficacies of β-cyclodextrin suspension were also evaluated in experimentally infected neonatal mice. Infection was prevented when the suspension was administered 2 hr before inoculated oocysts and on days 1 and 2 postinoculation.

José A. Castro-Hermida, Francisco Freire-Santos, Ángel M. Oteiza-López, and Elvira Ares-Mazás "UNEXPECTED ACTIVITY OF β-CYCLODEXTRIN AGAINST EXPERIMENTAL INFECTION BY CRYPTOSPORIDIUM PARVUM," Journal of Parasitology 86(5), 1118-1120, (1 October 2000). https://doi.org/10.1645/0022-3395(2000)086[1118:UAOCAE]2.0.CO;2
Received: 27 September 1999; Accepted: 1 February 2000; Published: 1 October 2000
JOURNAL ARTICLE
3 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top